Mandate

Axel Johnson AB become new principal owner of Mekonomen AB (publ)

October 02, 2006

Axel Johnson is becoming the new principal owner in Mekonomen by acquiring shares corresponding to 29 percent of the capital and votes from the Fraim and Möller families, after restamping all A-shares to B-shares. In connection with the acquisition of the shares, Axel Johnson AB has also agreed to an option that gives Axel Johnson AB the right to further acquire up to 9.9 percent of the total number of shares.

Vinge acted as advisor to the sellers Fraim and Möller. Representatives from Vinge included Carl Gustaf De Geer, Malin Ohlin Åkermark and Daniel Rosvall.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026